Global Bioinformatics Market Overview

The Bioinformatics Market is expected to grow at a significant growth rate, and the analysis period is 2022-2028, considering the base year as 2021.

In the context of genetics and genomics, bioinformatics is a subfield of biology that makes use of computers to collect, store, analyze, and disseminate biological data and information. Examples of this kind of data and information include the sequences of DNA and amino acids, as well as any annotations that are associated with those sequences. The study of bioinformatics encompasses not only biological research that incorporates the use of computer programming as a component of its technique but also unique analysis "pipelines" that are utilized several times, most notably in the field of genomics. The analysis of single nucleotide polymorphisms and the identification of candidate genes are both common applications of bioinformatics (SNPs).

It is anticipated that the global market for bioinformatics will experience significant expansion as a result of an increase in the demand for integrated data, an increase in the demand for nucleic acid and protein sequencing as a result of a decrease in the cost of sequencing, and an increase in the number of applications of proteomics and genomics. This is all expected to contribute to the growth of the market. In addition, it is anticipated that initiatives from both public and private organizations, as well as discoveries and advancements in pharmaceutical research, will contribute to the expansion of the market over the course of the period that is projected.

Market Dynamics And Factors For Bioinformatics Market

Drivers:

• Increasing Public-Private Sector Funding for Bioinformatics

Restraints:

• High Equipment Cost

Opportunity:

• Integration of Machine Learning & AI in Healthcare

Regional Analysis in Bioinformatics Market

North America is expected to have the maximum market share during the forthcoming year. This is because there has been an increase in the use of more advanced technology, in addition to an increase in the demand for improved bioinformatics tools, which are essential in the process of drug research and development. It is anticipated that the market in LAMEA will expand at the rate that is highest over the course of the forecast period. This is due to the fact that recent advancements in genomics and proteomics produce enormous amounts of data that need to be evaluated and managed. In addition, the region's research activities are gradually expanding, but the bioinformatics industry is still in its infant stages. As a consequence of this, each of these factors contributes to the growth of the market.

Covid-19 Impact Analysis On Bioinformatics Market

The COVID-19 epidemic boosted the expansion of the global bioinformatics market. The use of bioinformatics to detect viruses early has created new growth potential for the global bioinformatics market. Bioinformatics has also been employed in the development of medications and vaccines. Moreover, several strategic collaborations were developed in the worldwide bioinformatics sector during the COVID-19 pandemic. For instance, the government of the United Kingdom (UK) announced in March 2020 the establishment of the COVID-19 Genomics UK Consortium, along with an investment of twenty-one million dollars to use genome sequencing to sequence the genomes of SARS-CoV-2, the virus that was responsible for the COVID-19 outbreak. Public Health Agencies, the National Health Service (NHS), and a number of other research organizations are all members of the COVID-19 Genomics UK Consortium.

Top Key Players Covered In Bioinformatics Market

• Agilent Technologies Inc. (United States)
• Biomax Informatics Ag (Germany)
• Hybrigenics (France)
• Lumenogix (India)
• Dnanexus, Inc. (United States)
• Genedata Ag (Switzerland)
• Intrexon Bioinformatics Germany Gmbh (Germany)
• Illumina Inc. (United States)
• Perkinelmer Inc. (United States)
• Qiagen N.V. (Germany)
• Seven Bridges Genomics Inc. (United States)
• Thermo Fisher Scientific Inc. (United States), and Other Major Players

Key Industry Development In The Bioinformatics Market

In January 2022, Thermo Fisher completed the acquisition of PeproTech on December 30 2021 for a total cash purchase price of approximately US$ 1 85 billion PeproTech is a privately held provider of bioscience reagents known as recombinant proteins including cytokines and growth factors. Recombinant proteins are used in the development and manufacturing of cell and gene therapies, as well as in broader cell culture applications, especially for use in cellular research modeis

In May 2022, Bruker Corporation and TOFWERK AG announced a strategic partnership for high-speed ultra-sensitive applied and industrial analytical solutions, in conjunction with a Bruker minority investment in TOFWERK the partnership provides a basis for technology collaborations to advance instrument capabilities and for the development of novel analytical applications where high speed and ultra-sensitivity matter.

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Technology & Services
 3.2 By Application
 3.3 By Sectors

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 5: Bioinformatics Market by Technology & Services
 5.1 Bioinformatics Market Overview Snapshot and Growth Engine
 5.2 Bioinformatics Market Overview
 5.3 Knowledge Management Tools
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Knowledge Management Tools: Geographic Segmentation
 5.4 Bioinformatics Platforms
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Bioinformatics Platforms: Geographic Segmentation
 5.5 Bioinformatics Services
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2016-2028F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Bioinformatics Services: Geographic Segmentation

Chapter 6: Bioinformatics Market by Application
 6.1 Bioinformatics Market Overview Snapshot and Growth Engine
 6.2 Bioinformatics Market Overview
 6.3 Metabolomics
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2016-2028F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Metabolomics: Geographic Segmentation
 6.4 Molecular Phylogenetics
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2016-2028F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Molecular Phylogenetics: Geographic Segmentation
 6.5 Transcriptomics
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size (2016-2028F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Transcriptomics: Geographic Segmentation
 6.6 Proteomics
  6.6.1 Introduction and Market Overview
  6.6.2 Historic and Forecasted Market Size (2016-2028F)
  6.6.3 Key Market Trends, Growth Factors and Opportunities
  6.6.4 Proteomics: Geographic Segmentation
 6.7 Others
  6.7.1 Introduction and Market Overview
  6.7.2 Historic and Forecasted Market Size (2016-2028F)
  6.7.3 Key Market Trends, Growth Factors and Opportunities
  6.7.4 Others: Geographic Segmentation

Chapter 7: Bioinformatics Market by Sectors
 7.1 Bioinformatics Market Overview Snapshot and Growth Engine
 7.2 Bioinformatics Market Overview
 7.3 Medical Bioinformatics
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size (2016-2028F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Medical Bioinformatics: Geographic Segmentation
 7.4 Animal Bioinformatics
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size (2016-2028F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Animal Bioinformatics: Geographic Segmentation
 7.5 Agriculture Bioinformatics
  7.5.1 Introduction and Market Overview
  7.5.2 Historic and Forecasted Market Size (2016-2028F)
  7.5.3 Key Market Trends, Growth Factors and Opportunities
  7.5.4 Agriculture Bioinformatics: Geographic Segmentation
 7.6 Academics
  7.6.1 Introduction and Market Overview
  7.6.2 Historic and Forecasted Market Size (2016-2028F)
  7.6.3 Key Market Trends, Growth Factors and Opportunities
  7.6.4 Academics: Geographic Segmentation
 7.7 Others
  7.7.1 Introduction and Market Overview
  7.7.2 Historic and Forecasted Market Size (2016-2028F)
  7.7.3 Key Market Trends, Growth Factors and Opportunities
  7.7.4 Others: Geographic Segmentation

Chapter 8: Company Profiles and Competitive Analysis
 8.1 Competitive Landscape
  8.1.1 Competitive Positioning
  8.1.2 Bioinformatics Sales and Market Share By Players
  8.1.3 Industry BCG Matrix
  8.1.4 Heat Map Analysis
  8.1.5 Bioinformatics Industry Concentration Ratio (CR5 and HHI)
  8.1.6 Top 5 Bioinformatics Players Market Share
  8.1.7 Mergers and Acquisitions
  8.1.8 Business Strategies By Top Players
 8.2 AGILENT TECHNOLOGIES INC. (UNITED STATES)
  8.2.1 Company Overview
  8.2.2 Key Executives
  8.2.3 Company Snapshot
  8.2.4 Operating Business Segments
  8.2.5 Product Portfolio
  8.2.6 Business Performance
  8.2.7 Key Strategic Moves and Recent Developments
  8.2.8 SWOT Analysis
 8.3 BIOMAX INFORMATICS AG (GERMANY)
 8.4 HYBRIGENICS (FRANCE)
 8.5 LUMENOGIX (INDIA)
 8.6 DNANEXUS INC. (UNITED STATES)
 8.7 GENEDATA AG (SWITZERLAND)
 8.8 INTREXON BIOINFORMATICS GERMANY GMBH (GERMANY)
 8.9 ILLUMINA INC. (UNITED STATES)
 8.10 PERKINELMER INC. (UNITED STATES)
 8.11 QIAGEN N.V. (GERMANY)
 8.12 SEVEN BRIDGES GENOMICS INC. (UNITED STATES)
 8.13 THERMO FISHER SCIENTIFIC INC. (UNITED STATES)
 8.14 OTHER MAJOR PLAYERS

Chapter 9: Global Bioinformatics Market Analysis, Insights and Forecast, 2016-2028
 9.1 Market Overview
 9.2 Historic and Forecasted Market Size By Technology & Services
  9.2.1 Knowledge Management Tools
  9.2.2 Bioinformatics Platforms
  9.2.3 Bioinformatics Services
 9.3 Historic and Forecasted Market Size By Application
  9.3.1 Metabolomics
  9.3.2 Molecular Phylogenetics
  9.3.3 Transcriptomics
  9.3.4 Proteomics
  9.3.5 Others
 9.4 Historic and Forecasted Market Size By Sectors
  9.4.1 Medical Bioinformatics
  9.4.2 Animal Bioinformatics
  9.4.3 Agriculture Bioinformatics
  9.4.4 Academics
  9.4.5 Others

Chapter 10: North America Bioinformatics Market Analysis, Insights and Forecast, 2016-2028
 10.1 Key Market Trends, Growth Factors and Opportunities
 10.2 Impact of Covid-19
 10.3 Key Players
 10.4 Key Market Trends, Growth Factors and Opportunities
 10.4 Historic and Forecasted Market Size By Technology & Services
  10.4.1 Knowledge Management Tools
  10.4.2 Bioinformatics Platforms
  10.4.3 Bioinformatics Services
 10.5 Historic and Forecasted Market Size By Application
  10.5.1 Metabolomics
  10.5.2 Molecular Phylogenetics
  10.5.3 Transcriptomics
  10.5.4 Proteomics
  10.5.5 Others
 10.6 Historic and Forecasted Market Size By Sectors
  10.6.1 Medical Bioinformatics
  10.6.2 Animal Bioinformatics
  10.6.3 Agriculture Bioinformatics
  10.6.4 Academics
  10.6.5 Others
 10.7 Historic and Forecast Market Size by Country
  10.7.1 U.S.
  10.7.2 Canada
  10.7.3 Mexico

Chapter 11: Europe Bioinformatics Market Analysis, Insights and Forecast, 2016-2028
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Technology & Services
  11.4.1 Knowledge Management Tools
  11.4.2 Bioinformatics Platforms
  11.4.3 Bioinformatics Services
 11.5 Historic and Forecasted Market Size By Application
  11.5.1 Metabolomics
  11.5.2 Molecular Phylogenetics
  11.5.3 Transcriptomics
  11.5.4 Proteomics
  11.5.5 Others
 11.6 Historic and Forecasted Market Size By Sectors
  11.6.1 Medical Bioinformatics
  11.6.2 Animal Bioinformatics
  11.6.3 Agriculture Bioinformatics
  11.6.4 Academics
  11.6.5 Others
 11.7 Historic and Forecast Market Size by Country
  11.7.1 Germany
  11.7.2 U.K.
  11.7.3 France
  11.7.4 Italy
  11.7.5 Russia
  11.7.6 Spain
  11.7.7 Rest of Europe

Chapter 12: Asia-Pacific Bioinformatics Market Analysis, Insights and Forecast, 2016-2028
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Technology & Services
  12.4.1 Knowledge Management Tools
  12.4.2 Bioinformatics Platforms
  12.4.3 Bioinformatics Services
 12.5 Historic and Forecasted Market Size By Application
  12.5.1 Metabolomics
  12.5.2 Molecular Phylogenetics
  12.5.3 Transcriptomics
  12.5.4 Proteomics
  12.5.5 Others
 12.6 Historic and Forecasted Market Size By Sectors
  12.6.1 Medical Bioinformatics
  12.6.2 Animal Bioinformatics
  12.6.3 Agriculture Bioinformatics
  12.6.4 Academics
  12.6.5 Others
 12.7 Historic and Forecast Market Size by Country
  12.7.1 China
  12.7.2 India
  12.7.3 Japan
  12.7.4 Singapore
  12.7.5 Australia
  12.7.6 New Zealand
  12.7.7 Rest of APAC

Chapter 13: Middle East & Africa Bioinformatics Market Analysis, Insights and Forecast, 2016-2028
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Technology & Services
  13.4.1 Knowledge Management Tools
  13.4.2 Bioinformatics Platforms
  13.4.3 Bioinformatics Services
 13.5 Historic and Forecasted Market Size By Application
  13.5.1 Metabolomics
  13.5.2 Molecular Phylogenetics
  13.5.3 Transcriptomics
  13.5.4 Proteomics
  13.5.5 Others
 13.6 Historic and Forecasted Market Size By Sectors
  13.6.1 Medical Bioinformatics
  13.6.2 Animal Bioinformatics
  13.6.3 Agriculture Bioinformatics
  13.6.4 Academics
  13.6.5 Others
 13.7 Historic and Forecast Market Size by Country
  13.7.1 Turkey
  13.7.2 Saudi Arabia
  13.7.3 Iran
  13.7.4 UAE
  13.7.5 Africa
  13.7.6 Rest of MEA

Chapter 14: South America Bioinformatics Market Analysis, Insights and Forecast, 2016-2028
 14.1 Key Market Trends, Growth Factors and Opportunities
 14.2 Impact of Covid-19
 14.3 Key Players
 14.4 Key Market Trends, Growth Factors and Opportunities
 14.4 Historic and Forecasted Market Size By Technology & Services
  14.4.1 Knowledge Management Tools
  14.4.2 Bioinformatics Platforms
  14.4.3 Bioinformatics Services
 14.5 Historic and Forecasted Market Size By Application
  14.5.1 Metabolomics
  14.5.2 Molecular Phylogenetics
  14.5.3 Transcriptomics
  14.5.4 Proteomics
  14.5.5 Others
 14.6 Historic and Forecasted Market Size By Sectors
  14.6.1 Medical Bioinformatics
  14.6.2 Animal Bioinformatics
  14.6.3 Agriculture Bioinformatics
  14.6.4 Academics
  14.6.5 Others
 14.7 Historic and Forecast Market Size by Country
  14.7.1 Brazil
  14.7.2 Argentina
  14.7.3 Rest of SA

Chapter 15 Investment Analysis

Chapter 16 Analyst Viewpoint and Conclusion

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. BIOINFORMATICS MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. BIOINFORMATICS MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. BIOINFORMATICS MARKET COMPETITIVE RIVALRY
TABLE 005. BIOINFORMATICS MARKET THREAT OF NEW ENTRANTS
TABLE 006. BIOINFORMATICS MARKET THREAT OF SUBSTITUTES
TABLE 007. BIOINFORMATICS MARKET BY TECHNOLOGY & SERVICES
TABLE 008. KNOWLEDGE MANAGEMENT TOOLS MARKET OVERVIEW (2016-2028)
TABLE 009. BIOINFORMATICS PLATFORMS MARKET OVERVIEW (2016-2028)
TABLE 010. BIOINFORMATICS SERVICES MARKET OVERVIEW (2016-2028)
TABLE 011. BIOINFORMATICS MARKET BY APPLICATION
TABLE 012. METABOLOMICS MARKET OVERVIEW (2016-2028)
TABLE 013. MOLECULAR PHYLOGENETICS MARKET OVERVIEW (2016-2028)
TABLE 014. TRANSCRIPTOMICS MARKET OVERVIEW (2016-2028)
TABLE 015. PROTEOMICS MARKET OVERVIEW (2016-2028)
TABLE 016. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 017. BIOINFORMATICS MARKET BY SECTORS
TABLE 018. MEDICAL BIOINFORMATICS MARKET OVERVIEW (2016-2028)
TABLE 019. ANIMAL BIOINFORMATICS MARKET OVERVIEW (2016-2028)
TABLE 020. AGRICULTURE BIOINFORMATICS MARKET OVERVIEW (2016-2028)
TABLE 021. ACADEMICS MARKET OVERVIEW (2016-2028)
TABLE 022. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 023. NORTH AMERICA BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES (2016-2028)
TABLE 024. NORTH AMERICA BIOINFORMATICS MARKET, BY APPLICATION (2016-2028)
TABLE 025. NORTH AMERICA BIOINFORMATICS MARKET, BY SECTORS (2016-2028)
TABLE 026. N BIOINFORMATICS MARKET, BY COUNTRY (2016-2028)
TABLE 027. EUROPE BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES (2016-2028)
TABLE 028. EUROPE BIOINFORMATICS MARKET, BY APPLICATION (2016-2028)
TABLE 029. EUROPE BIOINFORMATICS MARKET, BY SECTORS (2016-2028)
TABLE 030. BIOINFORMATICS MARKET, BY COUNTRY (2016-2028)
TABLE 031. ASIA PACIFIC BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES (2016-2028)
TABLE 032. ASIA PACIFIC BIOINFORMATICS MARKET, BY APPLICATION (2016-2028)
TABLE 033. ASIA PACIFIC BIOINFORMATICS MARKET, BY SECTORS (2016-2028)
TABLE 034. BIOINFORMATICS MARKET, BY COUNTRY (2016-2028)
TABLE 035. MIDDLE EAST & AFRICA BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES (2016-2028)
TABLE 036. MIDDLE EAST & AFRICA BIOINFORMATICS MARKET, BY APPLICATION (2016-2028)
TABLE 037. MIDDLE EAST & AFRICA BIOINFORMATICS MARKET, BY SECTORS (2016-2028)
TABLE 038. BIOINFORMATICS MARKET, BY COUNTRY (2016-2028)
TABLE 039. SOUTH AMERICA BIOINFORMATICS MARKET, BY TECHNOLOGY & SERVICES (2016-2028)
TABLE 040. SOUTH AMERICA BIOINFORMATICS MARKET, BY APPLICATION (2016-2028)
TABLE 041. SOUTH AMERICA BIOINFORMATICS MARKET, BY SECTORS (2016-2028)
TABLE 042. BIOINFORMATICS MARKET, BY COUNTRY (2016-2028)
TABLE 043. AGILENT TECHNOLOGIES INC. (UNITED STATES): SNAPSHOT
TABLE 044. AGILENT TECHNOLOGIES INC. (UNITED STATES): BUSINESS PERFORMANCE
TABLE 045. AGILENT TECHNOLOGIES INC. (UNITED STATES): PRODUCT PORTFOLIO
TABLE 046. AGILENT TECHNOLOGIES INC. (UNITED STATES): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 046. BIOMAX INFORMATICS AG (GERMANY): SNAPSHOT
TABLE 047. BIOMAX INFORMATICS AG (GERMANY): BUSINESS PERFORMANCE
TABLE 048. BIOMAX INFORMATICS AG (GERMANY): PRODUCT PORTFOLIO
TABLE 049. BIOMAX INFORMATICS AG (GERMANY): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 049. HYBRIGENICS (FRANCE): SNAPSHOT
TABLE 050. HYBRIGENICS (FRANCE): BUSINESS PERFORMANCE
TABLE 051. HYBRIGENICS (FRANCE): PRODUCT PORTFOLIO
TABLE 052. HYBRIGENICS (FRANCE): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 052. LUMENOGIX (INDIA): SNAPSHOT
TABLE 053. LUMENOGIX (INDIA): BUSINESS PERFORMANCE
TABLE 054. LUMENOGIX (INDIA): PRODUCT PORTFOLIO
TABLE 055. LUMENOGIX (INDIA): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 055. DNANEXUS INC. (UNITED STATES): SNAPSHOT
TABLE 056. DNANEXUS INC. (UNITED STATES): BUSINESS PERFORMANCE
TABLE 057. DNANEXUS INC. (UNITED STATES): PRODUCT PORTFOLIO
TABLE 058. DNANEXUS INC. (UNITED STATES): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 058. GENEDATA AG (SWITZERLAND): SNAPSHOT
TABLE 059. GENEDATA AG (SWITZERLAND): BUSINESS PERFORMANCE
TABLE 060. GENEDATA AG (SWITZERLAND): PRODUCT PORTFOLIO
TABLE 061. GENEDATA AG (SWITZERLAND): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 061. INTREXON BIOINFORMATICS GERMANY GMBH (GERMANY): SNAPSHOT
TABLE 062. INTREXON BIOINFORMATICS GERMANY GMBH (GERMANY): BUSINESS PERFORMANCE
TABLE 063. INTREXON BIOINFORMATICS GERMANY GMBH (GERMANY): PRODUCT PORTFOLIO
TABLE 064. INTREXON BIOINFORMATICS GERMANY GMBH (GERMANY): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 064. ILLUMINA INC. (UNITED STATES): SNAPSHOT
TABLE 065. ILLUMINA INC. (UNITED STATES): BUSINESS PERFORMANCE
TABLE 066. ILLUMINA INC. (UNITED STATES): PRODUCT PORTFOLIO
TABLE 067. ILLUMINA INC. (UNITED STATES): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 067. PERKINELMER INC. (UNITED STATES): SNAPSHOT
TABLE 068. PERKINELMER INC. (UNITED STATES): BUSINESS PERFORMANCE
TABLE 069. PERKINELMER INC. (UNITED STATES): PRODUCT PORTFOLIO
TABLE 070. PERKINELMER INC. (UNITED STATES): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 070. QIAGEN N.V. (GERMANY): SNAPSHOT
TABLE 071. QIAGEN N.V. (GERMANY): BUSINESS PERFORMANCE
TABLE 072. QIAGEN N.V. (GERMANY): PRODUCT PORTFOLIO
TABLE 073. QIAGEN N.V. (GERMANY): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 073. SEVEN BRIDGES GENOMICS INC. (UNITED STATES): SNAPSHOT
TABLE 074. SEVEN BRIDGES GENOMICS INC. (UNITED STATES): BUSINESS PERFORMANCE
TABLE 075. SEVEN BRIDGES GENOMICS INC. (UNITED STATES): PRODUCT PORTFOLIO
TABLE 076. SEVEN BRIDGES GENOMICS INC. (UNITED STATES): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 076. THERMO FISHER SCIENTIFIC INC. (UNITED STATES): SNAPSHOT
TABLE 077. THERMO FISHER SCIENTIFIC INC. (UNITED STATES): BUSINESS PERFORMANCE
TABLE 078. THERMO FISHER SCIENTIFIC INC. (UNITED STATES): PRODUCT PORTFOLIO
TABLE 079. THERMO FISHER SCIENTIFIC INC. (UNITED STATES): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 079. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 080. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 081. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 082. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. BIOINFORMATICS MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. BIOINFORMATICS MARKET OVERVIEW BY TECHNOLOGY & SERVICES
FIGURE 012. KNOWLEDGE MANAGEMENT TOOLS MARKET OVERVIEW (2016-2028)
FIGURE 013. BIOINFORMATICS PLATFORMS MARKET OVERVIEW (2016-2028)
FIGURE 014. BIOINFORMATICS SERVICES MARKET OVERVIEW (2016-2028)
FIGURE 015. BIOINFORMATICS MARKET OVERVIEW BY APPLICATION
FIGURE 016. METABOLOMICS MARKET OVERVIEW (2016-2028)
FIGURE 017. MOLECULAR PHYLOGENETICS MARKET OVERVIEW (2016-2028)
FIGURE 018. TRANSCRIPTOMICS MARKET OVERVIEW (2016-2028)
FIGURE 019. PROTEOMICS MARKET OVERVIEW (2016-2028)
FIGURE 020. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 021. BIOINFORMATICS MARKET OVERVIEW BY SECTORS
FIGURE 022. MEDICAL BIOINFORMATICS MARKET OVERVIEW (2016-2028)
FIGURE 023. ANIMAL BIOINFORMATICS MARKET OVERVIEW (2016-2028)
FIGURE 024. AGRICULTURE BIOINFORMATICS MARKET OVERVIEW (2016-2028)
FIGURE 025. ACADEMICS MARKET OVERVIEW (2016-2028)
FIGURE 026. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 027. NORTH AMERICA BIOINFORMATICS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 028. EUROPE BIOINFORMATICS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 029. ASIA PACIFIC BIOINFORMATICS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 030. MIDDLE EAST & AFRICA BIOINFORMATICS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 031. SOUTH AMERICA BIOINFORMATICS MARKET OVERVIEW BY COUNTRY (2016-2028)